Method development and validation for the simultaneous determination of fluoxetine and fluvoxamine in pharmaceutical preparations by capillary electrophoresis
- 24 July 2000
- journal article
- Published by Elsevier in Analytica Chimica Acta
- Vol. 417 (2) , 169-176
- https://doi.org/10.1016/s0003-2670(00)00926-0
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Determination of fluoxetine and its metabolite norfluoxetine in serum and brain areas using high-performance liquid chromatography with ultraviolet detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1998
- Determination of Fluvoxamine and Paroxetine in Human Serum with High-Performance Liquid Chromatography and Ultraviolet DetectionJournal of Liquid Chromatography & Related Technologies, 1997
- Analytical methods for the quantitative determination of selective serotonin reuptake inhibitors for therapeutic drug monitoring purposes in patientsJournal of Chromatography B: Biomedical Sciences and Applications, 1996
- Evaluation of different techniques for peak purity assessment on a diode-array detector in liquid chromatographyJournal of Chromatography A, 1995
- The validation of analytical methods for drug substances and drug products in UK pharmaceutical laboratoriesJournal of Pharmaceutical and Biomedical Analysis, 1994
- Safety and antidepressant efficacy of selective serotonin re‐uptake inhibitorsHuman Psychopharmacology: Clinical and Experimental, 1994
- Determination of fluoxetine and norfluoxetine in human plasma by capillary gas chromatography with electron-capture detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1993
- A comprehensive method validation strategy for bioanalytical applications in the pharmaceutical industry — 1. Experimental considerationsJournal of Pharmaceutical and Biomedical Analysis, 1991